• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤治疗电场与联合疗法在脑肿瘤治疗中的应用

Tumor Treating Fields and Combination Therapy in Management of Brain Oncology.

作者信息

Liu Ruisi Nicole, Huang James H, Qi Xiaoming, Pan Yizhong, Wu Erxi, Nizamutdinov Damir

机构信息

Department of Neurosurgery and Neuroscience Institute, Baylor Scott & White Health, Temple, TX 76508, USA.

Department of Neurology, Baylor Scott & White Health, Temple, TX 76508, USA.

出版信息

Cancers (Basel). 2025 Apr 2;17(7):1211. doi: 10.3390/cancers17071211.

DOI:10.3390/cancers17071211
PMID:40227773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11987984/
Abstract

Glioblastoma (GBM) remains a challenging cancer to treat with limited effective therapies. Standard treatments, including surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy, offer marginal survival benefits but are often limited by side effects and drug resistance. Temozolomide is the most commonly used chemotherapy; however, resistance and lack of efficacy in recurrent GBM hinder its success. Tumor treating fields (TTFields), a novel non-invasive modality that utilizes alternating electric fields, have recently emerged as a promising treatment for GBM. TTFields work by disrupting the function of the mitotic spindle and inducing apoptosis in cancer cells. They can be especially effective when combined with other therapies. TTFields enhance drug delivery when paired with chemotherapy by increasing the permeability of the blood-brain barrier and cell membranes, leading to more effective tumor inhibition. Similarly, TTFields increase cancer cell sensitivity to radiation therapy and improve the efficacy of targeted therapies, such as sorafenib and immunotherapy, particularly in extra-cranial tumors. The Optune device, the primary medical device for TTFields' delivery, offers a convenient and versatile treatment option, allowing remote care and exhibiting fewer adverse effects. This review discusses the potential of TTFields as a valuable addition to GBM treatment, particularly in combination therapies, and highlights the device's clinical applications.

摘要

胶质母细胞瘤(GBM)仍然是一种治疗具有挑战性的癌症,有效治疗方法有限。包括手术、放疗、化疗、靶向治疗和免疫治疗在内的标准治疗方法仅能带来有限的生存益处,且常常受到副作用和耐药性的限制。替莫唑胺是最常用的化疗药物;然而,复发性GBM中的耐药性和疗效不佳阻碍了其治疗效果。肿瘤治疗电场(TTFields)是一种利用交变电场的新型非侵入性治疗方式,最近已成为GBM的一种有前景的治疗方法。TTFields通过破坏有丝分裂纺锤体的功能并诱导癌细胞凋亡来发挥作用。当与其他疗法联合使用时,它们可能会特别有效。TTFields与化疗联合使用时,通过增加血脑屏障和细胞膜的通透性来增强药物递送,从而更有效地抑制肿瘤。同样,TTFields可提高癌细胞对放射治疗的敏感性,并提高靶向治疗(如索拉非尼)和免疫治疗的疗效,特别是在颅外肿瘤中。Optune设备是用于递送TTFields的主要医疗设备,提供了一种方便且通用的治疗选择,允许远程护理且不良反应较少。本综述讨论了TTFields作为GBM治疗中一种有价值的补充方法的潜力,特别是在联合治疗中,并强调了该设备的临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6803/11987984/bc301a8b1423/cancers-17-01211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6803/11987984/cf0d21fec230/cancers-17-01211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6803/11987984/bc301a8b1423/cancers-17-01211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6803/11987984/cf0d21fec230/cancers-17-01211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6803/11987984/bc301a8b1423/cancers-17-01211-g002.jpg

相似文献

1
Tumor Treating Fields and Combination Therapy in Management of Brain Oncology.肿瘤治疗电场与联合疗法在脑肿瘤治疗中的应用
Cancers (Basel). 2025 Apr 2;17(7):1211. doi: 10.3390/cancers17071211.
2
The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.肿瘤治疗电场在胶质母细胞瘤管理中的演变作用:肿瘤学家指南
Am J Clin Oncol. 2018 Feb;41(2):191-196. doi: 10.1097/COC.0000000000000395.
3
Tumor treating fields: a comprehensive overview of the underlying molecular mechanism.肿瘤治疗电场:潜在分子机制的全面概述。
Expert Rev Mol Diagn. 2022 Jan;22(1):19-28. doi: 10.1080/14737159.2022.2017283. Epub 2021 Dec 28.
4
Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.肿瘤治疗电场:一种治疗胶质母细胞瘤的新型有效疗法:作用机制、疗效、安全性及未来展望
Chin Clin Oncol. 2017 Aug;6(4):41. doi: 10.21037/cco.2017.06.29.
5
Tumour treating fields in a combinational therapeutic approach.组合治疗方法中的肿瘤治疗电场
Oncotarget. 2018 Nov 27;9(93):36631-36644. doi: 10.18632/oncotarget.26344.
6
Tumor Treating Fields in the Management of Patients with Malignant Gliomas.肿瘤电场治疗恶性脑胶质瘤患者的应用。
Curr Treat Options Oncol. 2020 Jul 30;21(9):76. doi: 10.1007/s11864-020-00773-5.
7
Enhancing glioblastoma treatment through the integration of tumor-treating fields.通过整合肿瘤治疗电场增强胶质母细胞瘤的治疗效果。
Front Oncol. 2023 Oct 17;13:1274587. doi: 10.3389/fonc.2023.1274587. eCollection 2023.
8
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma.胶质母细胞瘤肿瘤电场(TTFields)治疗的最新进展。
Oncologist. 2025 Feb 6;30(2). doi: 10.1093/oncolo/oyae227.
9
The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy.肿瘤治疗电场(TTFields)单独使用或与放疗及化疗联合使用的方案、机制和分子途径变化。
Cell Death Discov. 2022 Oct 11;8(1):416. doi: 10.1038/s41420-022-01206-y.
10
An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications.肿瘤治疗电场诱导癌细胞死亡的潜在新作用机制概述及其临床意义。
Int J Radiat Biol. 2021;97(8):1044-1054. doi: 10.1080/09553002.2020.1837984. Epub 2020 Oct 29.

本文引用的文献

1
Ultrasound-Responsive Nanobubbles for Breast Cancer: Synergistic Sonodynamic, Chemotherapy, and Immune Activation through the cGAS-STING Pathway.用于乳腺癌的超声响应纳米气泡:通过cGAS-STING途径实现协同声动力、化疗和免疫激活
ACS Appl Mater Interfaces. 2025 Apr 2;17(13):19317-19334. doi: 10.1021/acsami.4c21493. Epub 2025 Mar 24.
2
2,9-Diaryl-6,13-bis(triisopropylsilylethynyl)pentacene derivatives: synthesis and application in cancer sonodynamic therapy.2,9-二芳基-6,13-双(三异丙基甲硅烷基乙炔基)并五苯衍生物:合成及其在癌症声动力治疗中的应用
Chem Commun (Camb). 2025 Mar 27;61(27):5174-5177. doi: 10.1039/d5cc00326a.
3
Blocking Feedback Immunosuppression of Antigen Presentation in Brain Tumor During Oncolytic Virotherapy with oHSV-mshPKR.
在使用oHSV-mshPKR进行溶瘤病毒治疗期间,阻断脑肿瘤中抗原呈递的反馈免疫抑制。
Mol Cancer Ther. 2025 Mar 4;24(3):444-452. doi: 10.1158/1535-7163.MCT-24-0629.
4
Oncolytic Virotherapies and Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against Malignant Gliomas.溶瘤病毒治疗与辅助肠道微生物组治疗以提高恶性脑胶质瘤的疗效。
Viruses. 2024 Nov 14;16(11):1775. doi: 10.3390/v16111775.
5
CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws.嵌合抗原受体工程化自然杀伤细胞与嵌合抗原受体T细胞治疗胶质母细胞瘤的比较;优势与不足
J Neurooncol. 2025 Feb;171(3):495-530. doi: 10.1007/s11060-024-04876-z. Epub 2024 Nov 13.
6
Targeted sonodynamic therapy induces tumor cell quasi-immunogenic ferroptosis and macrophage immunostimulatory autophagy in glioblastoma.靶向声动力疗法可诱导胶质母细胞瘤中的肿瘤细胞发生准免疫原性铁死亡及巨噬细胞免疫刺激自噬。
Biomaterials. 2025 Apr;315:122913. doi: 10.1016/j.biomaterials.2024.122913. Epub 2024 Oct 28.
7
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma.胶质母细胞瘤肿瘤电场(TTFields)治疗的最新进展。
Oncologist. 2025 Feb 6;30(2). doi: 10.1093/oncolo/oyae227.
8
Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model.颅内注射 B7-H3 靶向 Car-T 和 Car-NK 细胞在患者来源的胶质母细胞瘤异种移植模型中的抗肿瘤作用。
Cancer Immunol Immunother. 2024 Oct 5;73(12):256. doi: 10.1007/s00262-024-03808-0.
9
Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer.聚焦超声辅助递送免疫调节药物治疗脑肿瘤。
J Control Release. 2024 Mar;367:283-299. doi: 10.1016/j.jconrel.2024.01.034. Epub 2024 Jan 29.
10
Advances in Focused Ultrasound for the Treatment of Brain Tumors.聚焦超声在脑肿瘤治疗中的进展。
Tomography. 2023 May 29;9(3):1094-1109. doi: 10.3390/tomography9030090.